Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Trifluoperazine hydrochloride 2.36mg equivalent to 2 mg trifluoperazine;
Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)
Trifluoperazine hydrochloride 2.36 mg (equivalent to 2 mg trifluoperazine)
2 mg
Film coated tablet
Active: Trifluoperazine hydrochloride 2.36mg equivalent to 2 mg trifluoperazine Excipient: Calcium sulfate dihydrate Gelatin Maize starch Opadry blue OY-4492 Purified talc Purified water as solvent Stearic acid Sucrose
Blister pack, 50 tablets
Prescription
Prescription
Egis Pharmaceuticals Ltd
Chronic therapy In high doses for management of manifestations of psychotic disorders, such as acute and chronic catatonic hebephrenic and paranoid schizophrenia, psychosis due to organic brain damage, toxic psychosis, manic depressive psychosis, senile psychosis and mental deficiency. Short-term therapy Treatment of acute alcoholism for the relief of delusons, hallucinations and confused state, and for the control of accompanying tremulousness and aggressive behaviour. In low doses to control excessive anxiety, tension and agitation as seen in neuroses or associated with somatic conditions. Stelazine is not recommended as first line therapy in patients with non-psychotic anxiety disorders, nor should therapy be carried out for more than 12 weeks. For nausea and vomiting of various causes.
Package - Contents - Shelf Life: Blister pack, - 50 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVDC blister - 100 tablets - 36 months from date of manufacture stored at or below 30°C
1969-12-31
Stelazine (trifluoperazine hydrochloride) Page 1 of 10 CONSUMER MEDICINE INFORMATION STELAZINE ® _TRIFLUOPERAZINE HYDROCHLORIDE _ _ _ Film-coated tablets 1 mg, 2 mg and 5 mg WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start taking Stelazine. This leaflet answers some common questions about Stelazine. It does not contain all the available information. Reading this leaflet does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Stelazine against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT STELAZINE IS USED FOR Stelazine contains trifluoperazine hydrochloride as the active ingredient. It belongs to a group of medicines called phenothiazine neuroleptics. It helps to correct chemical imbalances in the brain, which may cause mental illness. These chemicals may also affect the parts of the brain which control nausea and vomiting. Stelazine is used to treat mental illnesses with disturbances in thinking, feelings and behaviour. It may also be used to treat nausea and vomiting, or used short term in patients with severe anxiety, tension and agitation. Your doctor may have prescribed this medicine for another reason. ASK YOUR DOCTOR IF YOU HAVE QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FOR YOU. Stelazine is available only with a doctor's prescription. Stelazine is not addictive. Stelazine (trifluoperazine hydrochloride) Page 2 of 10 BEFORE YOU TAKE STELAZINE Stelazine is not suitable for everyone. _WHEN YOU MUST NOT TAKE IT _ Przeczytaj cały dokument
NEW ZEALAND DATA SHEET STELAZINE ® _Trifluoperazine dihydrochloride _ Tablets 1 mg, 2 mg and 5 mg Forte Liquid 1 mg/mL _(not available) _ Spansule 15 mg _(not available) _ PRESENTATIONS Tablets 1 mg, blue, film-coated, biconvex tablets. Tablets 2 mg, blue, film-coated, biconvex tablets. Tablets 5 mg, blue, film-coated, biconvex tablets. Forte Liquid, oral solution 1 mg/mL, clear, viscous liquid with a bitter orange taste. Spansule, modified release capsules 15 mg, size no. 1 hard gelatin capsule with opaque yellow cap and transparent colourless body containing a mixture of dark blue, light blue and white spherical pellets. Both body and cap are printed “15” in black. INDICATIONS CHRONIC THERAPY In high doses for management of manifestations of psychotic disorders, such as acute and chronic catatonic hebephrenic and paranoid schizophrenia, psychosis due to organic brain damage, toxic psychosis, manic depressive psychosis, senile psychosis and mental deficiency. SHORT-TERM THERAPY Treatment of acute alcoholism for the relief of delusions, hallucinations and confused state, and for the control of accompanying tremulousness and aggressive behaviour. In low doses to control excessive anxiety, tension and agitation as seen in neuroses or associated with somatic conditions. For nausea and vomiting of various causes. DOSAGE AND ADMINISTRATION Dosage should be tailored to the individual response, carefully monitored and adjusted accordingly. Because of the inherent long action of the drug, patients may be controlled on convenient twice daily administration. FOR OFFICE PATIENTS AND OUTPATIENTS Oral - adults: Usual dosage is 1 or 2 mg twice a day. If necessary, dosage may be increased to 6 mg a day, but above this level extrapyramidal symptoms are more likely to occur in some patients. Oral – Przeczytaj cały dokument